Pentobarbital

Pentobarbital

SCHEMBL3474760

CCCC(C)C1(CC)C(=O)N=C([O-])NC1=O.O=C(O)CCC(=O)O.[Na+]

nearest known ligand 0.48

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQ

The experimentally established mechanism targets of Pentobarbital. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
GABRB3 known ✓ P28472 1/20 0.48
GABRA2 known ✓ P47869 1/20 0.48
GABRB2 known ✓ P47870 1/20 0.48
CYP3A4 P08684 3/20 0.48
KDM4E B2RXH2 1/20 0.48
ALDH1A1 P00352 1/20 0.48
OPRD1 P41143 1/20 0.48
LMNA P02545 3/20 0.46
MMP9 P14780 1/20 0.37
POLB P06746 1/20 0.35
PKM P14618 1/20 0.35
NR1I2 O75469 1/20 0.34
RECQL P46063 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Pentobarbital SCHEMBL2688595 0.96 CYP3A4 (0.47) CYP3A4KDM4EALDH1A1GABRB3OPRD1
Pentobarbital SCHEMBL16240950 0.96 CYP3A4 (0.47) CYP3A4KDM4EALDH1A1GABRB3OPRD1
Pentobarbital SCHEMBL22265808 0.95 CYP3A4 (0.46) CYP3A4KDM4EALDH1A1GABRB3OPRD1
Pentobarbital SCHEMBL1419428 0.95 ALDH1A1 (0.49) CYP3A4KDM4EALDH1A1GABRB3OPRD1
Pentobarbital SCHEMBL2689394 0.94 CYP3A4 (0.49) CYP3A4KDM4EALDH1A1GABRB3OPRD1
Pentobarbital SCHEMBL2769858 0.94 CYP3A4 (0.51) CYP3A4KDM4EALDH1A1GABRB3OPRD1
Pentobarbital SCHEMBL22092117 0.93 CYP3A4 (0.44) CYP3A4KDM4EALDH1A1GABRB3OPRD1
Pentobarbital SCHEMBL7025367 0.93 ALDH1A1 (0.47) CYP3A4KDM4EALDH1A1GABRB3OPRD1
Pentobarbital SCHEMBL2715148 0.93 CYP3A4 (0.48) CYP3A4KDM4EALDH1A1GABRB3OPRD1
Pentobarbital SCHEMBL477033 0.92 CYP3A4 (0.50) CYP3A4KDM4EALDH1A1GABRB3OPRD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118530412-A Binder for negative electrode, negative electrode slurry, negative electrode, and lithium battery 深圳好电科技有限公司 2024-08-23 CN claimed
CN-118530412-A Binder for negative electrode, negative electrode slurry, negative electrode, and lithium battery 深圳好电科技有限公司 2024-08-23 CN disclosed
CN-109689792-B Liquid antioxidant composition for raw rubber 巴斯夫欧洲公司 2022-03-29 CN disclosed
CN-107099023-B Diketopyrrolo-pyrrole polymer for organic field effect tube 巴斯夫欧洲公司 2019-10-22 CN disclosed
US-10428194-B2 Modified acrylic resin cured product, and laminate thereof, and production methods therefor MITSUI CHEMICALS, INC. (JP) 2019-10-01 US disclosed
EP-3263635-B1 MODIFIED ACRYLIC RESIN CURED PRODUCT, AND LAMINATE THEREOF, AND PRODUCTION METHODS THEREFOR MITSUI CHEMICALS INC (JP) 2019-09-18 EP disclosed
US-20180163056-A1 HYDROPHILIC CURABLE COMPOSITIONS MITSUI CHEMICALS, INC. (JP) 2018-06-14 US disclosed
US-20180036995-A1 HYDROPHILIC MONOLAYER FILM WITH OPTICAL FUNCTIONALITY AND STACK OF THE SAME MITSUI CHEMICALS, INC. (JP) 2018-02-08 US disclosed
US-20180030230-A1 MODIFIED ACRYLIC RESIN CURED PRODUCT, AND LAMINATE THEREOF, AND PRODUCTION METHODS THEREFOR MITSUI CHEMICALS, INC. (JP) 2018-02-01 US disclosed
EP-3270192-A1 HYDROPHILIC SINGLE-LAYER FILM HAVING OPTICAL FUNCTIONALITY, AND LAMINATE THEREOF Mitsui Chemicals, Inc. (JP) 2018-01-17 EP disclosed
EP-3263635-A1 MODIFIED ACRYLIC RESIN CURED PRODUCT, AND LAMINATE THEREOF, AND PRODUCTION METHODS THEREFOR Mitsui Chemicals, Inc. (JP) 2018-01-03 EP disclosed
EP-3081578-A1 COMPOSITION FOR HYDROPHILIC CURED PRODUCT Mitsui Chemicals, Inc. (JP) 2016-10-19 EP disclosed
US-8586731-B2 Hydrophobic polysaccharides with diester- or carbonate ester-containing linkages having enhanced degradation SURMODICS, INC. (US) 2013-11-19 US disclosed
US-20100316687-A1 HYDROPHOBIC POLYSACCHARIDES WITH DIESTER- OR CARBONATE ESTER-CONTAINING LINKAGES HAVING ENHANCED DEGRADATION SURMODICS MD, LLC 2010-12-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100316687-A1 HYDROPHOBIC POLYSACCHARIDES WITH DIESTER- OR CARBONATE ESTER-CONTAINING LINKAGES HAVING ENHANCED DEGRADATION CD44, SI, ENGASE GABRB3 3846/4885GABRA2 4258/4885GABRB2 3930/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.